Post by Synendos Therapeutics AG

Synendos Therapeutics AG co-founder, Prof. Jürg Gertsch of the University of Bern, will be presenting the Presidential Plenary Lecture on 29 June at 12:00 CET, at the INTERNATIONAL CANNABINOID RESEARCH SOCIETY conference in Dijon - France:  A Druggable ACSL4 Isoform Moonlighting Function Facilitates Endocannabinoid Plasma-membrane Diffusion and Tunes CB1 Receptor Signaling #Anxiety #PTSD #MentalHealth #PsychiatryResearch #CNS #Synendos